Detail page

Knowledge Web

Person

Markus Robert Meyer

Name	Markus Robert Meyer
Place	Sonstiges Ausland / Unbekanntes Land
Academic degree	Prof. Dr.
Variant	Markus R. Meyer Markus Meyer
Further information	Diss. Universität des Saarlandes, Fakultät 8 - Naturwissenschaftlich-Technische Fakultät III, Chemie, Pharmazie, Bio- und Werkstoffwissenschaften (2009)
Record type	Person
GND-Identifier	139035974
Record ID	139035974
Involved in show all Cytotoxicity and toxicokinetics of new psychoactive substances In vitro and in vivo toxicometabolomics of the synthetic cathinone PCYP studied by means of LC-HRMS/MS In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS LC-HR-MS/MS library of drugs, poisons, and their metabolites Altered glucocorticoid metabolism represents a feature of macroph-aging Altered glucocorticoid metabolism represents a feature of macroph-aging LC-HR-MS/MS library of drugs, poisons, and their metabolites New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse? Enantiomers of methylenedioxy designer drugs : the role of cytochrome P450s and catechol-O-methyltransferase in their metabolism

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Markus Robert Meyer

Cytotoxicity and toxicokinetics of new psychoactive substances

In vitro and in vivo toxicometabolomics of the synthetic cathinone PCYP studied by means of LC-HRMS/MS

In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS

LC-HR-MS/MS library of drugs, poisons, and their metabolites

Altered glucocorticoid metabolism represents a feature of macroph-aging

Altered glucocorticoid metabolism represents a feature of macroph-aging

LC-HR-MS/MS library of drugs, poisons, and their metabolites

New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics

Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches

Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes

What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?

Enantiomers of methylenedioxy designer drugs : the role of cytochrome P450s and catechol-O-methyltransferase in their metabolism